Back to Dashboard
HAE · Healthcare

Haemonetics Corp Mass

USA Healthcare Filing: 2026-06-30
29/100
Smart-money confidence1 of 3 sources positive
Below average interest

No standout activity across the feeds we track.

What this band has actually done: stocks scoring 25–45 beat the S&P 500 over the next three months 45.3% of the time, across 39,662 cases since 2015. That is below a coin flip — and so is every other band, because the median stock loses to a cap-weighted index. How we measured this

Hedge funds
38
Congress
No data
Insiders
No data
Cross-source blend of hedge-fund breadth, Congress trades, and insider Form 4s.  ·  how the score works
Market cap
$4.8B
Industry
Medical Devices
Sector
Healthcare
Exchange
NYSE
About HAEMONETICS CORP MASS

Haemonetics Corporation, a medical technology company, provides a suite of hospital technologies solutions. The company operates through Plasma, Blood Center, and Hospital segments. It provides automated plasma collection systems, donor management software, and supporting software solutions, such as NexSys PCS plasmapheresis equipment system and related disposables and solutions, as well as integrated information technology platforms for plasma customers to manage their donors, operations, and supply chain; and NexLynk DMS donor management system and Donor360 tools. The company also offers…

Who's behind the signal
Every informed buyer we can see on HAE, across all three feeds.
Hedge funds · 8
Citadel Advisors Increased +485%
Point72 (Steve Cohen) Increased +92%
Renaissance Technologies Increased +201%
AQR Capital Management Decreased −32%
+2 more in the full breakdown below ↓
Congress · 3
Insiders
No significant Form 4 insider activity in the window.
Congressional trades · 10 on record
Disclosures from 2020-05-15 to 2021-05-07
The newest disclosure we hold for this stock is 2021-05-07. That is the end of our data, not necessarily the end of the trading — our bulk STOCK Act archive stops there and newer filings arrive through a separate live feed. Treat the absence of recent rows as “not covered”, not as “no trades”.
Trade date Member Chamber Action Amount
2021-05-07 Lois Frankel · D-FL House Sold $1,001 - $15,000
2021-05-06 Lois Frankel · D-FL House Sold $1,001 - $15,000
2021-01-25 Josh Gottheimer · D-NJ House Sold $1,001 - $15,000
2020-10-16 Josh Gottheimer · D-NJ House Bought $1,001 - $15,000
2020-09-15 Josh Gottheimer · D-NJ House Sold $1,001 - $15,000
2020-08-14 Lois Frankel · D-FL House Bought $1,001 - $15,000
2020-06-01 Gilbert Ray Cisneros, Jr. · D-CA House Bought $1,001 - $15,000
2020-05-28 Josh Gottheimer · D-NJ House Bought $1,001 - $15,000
2020-05-19 Gilbert Ray Cisneros, Jr. · D-CA House Bought $1,001 - $15,000
2020-05-15 Josh Gottheimer · D-NJ House Bought $1,001 - $15,000
Not a model pick — but on our radar. HAEMONETICS CORP MASS isn't in the top-10 model right now, but 8 tracked investors hold it. Everything below is real signal from public filings — treat this as a watch candidate, not a conviction call.
8
Investors
0
New positions
5
Increasing
3
Decreasing
0
Unchanged
Price History
Loading price data...
A member of Congress bought A member sold
Return: High: Low:

Markers sit on the transaction date the member disclosed, snapped to the nearest close on the chart. They are not the date the public found out — that came later, and the gap is its own page. Every marker is listed by name in the table above.

Who's Holding This Stock
Position sizes and recent activity from tracked institutional investors
Portfolio Allocation
How much of each investor's portfolio is allocated to HAEMONETICS CORP MASS
⚠ Disclaimer: This page is for informational purposes only. Holdings data from SEC EDGAR 13F filings, delayed up to 135 days. Not a recommendation to buy or sell HAEMONETICS CORP MASS or any security.

订阅每周更新

我们每周会把巴菲特、达利欧、阿克曼以及另外 47 位传奇投资人正在买入的股票发送给你 — 免费,直接来自他们的 SEC 申报文件。
永久免费 · 无垃圾邮件 · 随时退订